Literature DB >> 6972911

Rat erythrocytes elicit antibody formation against RT1.A region-determined antigens in allogeneic recipients.

G D Majoor, M J Van de Gaar, P J Van Breda Vriesman, E Günther.   

Abstract

Highly purified erythrocytes of inbred LEW (RT1(1)) rats (LEW-E) elicited antibody responses in inbred BN (RT1n) rats. Intravenous infusion of 1 X 10(8) LEW-E elicited IgM haemagglutinins and after one further infusion of LEW-E IgG haemagglutinins were raised as well. These haemagglutinins were mainly directed to RT1.A region-determined classical transplantation antigens but a weak response to non-RT1 minor histocompatibility antigens was also obtained. In the reciprocal combination erythrocytes of BN and LEW.1N rats, which carry the RT1n haplotype on the LEW strain genetic background, infused into LEW rats yielded strong IgM haemagglutinin responses to RT1.A antigens only but failed to elicit IgG antibody. Infusion of LEW.1N rats with LEW-E elicited only weak IgM haemagglutinin responses. These findings demonstrate that RT1.A antigens are immunogenic for they elicit IgM alloantibody responses. IgG haemagglutinin responses to LEW-E may depend on the presence of minor histocompatibility antigens in conjunction with RT1.A antigens on LEW-E or alternatively on control by Ir-genes located outside the RT1 complex.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6972911      PMCID: PMC1555049     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  Cytotoxic and enhancing properties of early gammaM alloantibodies elicited by first set renal allografts. In vitro and in vivo studies with rat and guinea pig complement on somatic target cells with varying antigen density.

Authors:  P J van Breda Vriesman; L Swanen-Sierag; L F Vlek
Journal:  Transplantation       Date:  1975-11       Impact factor: 4.939

2.  The immune response to allogeneic rat platelets; Ag-B antigens in matrix form lacking Ia.

Authors:  K I Welsh; H Burgos; J R Batchelor
Journal:  Eur J Immunol       Date:  1977-05       Impact factor: 5.532

3.  The alloantibody response to a strong transplantation antigen (Ag-B). Quantitative aspects and thymus dependence of the response.

Authors:  B Rolstad; A F Williams; W L Ford
Journal:  Transplantation       Date:  1974-04       Impact factor: 4.939

4.  The effect of neonatal thymectomy on antibody responses to histocompatibility antigens in the rat.

Authors:  C L Miller; C W DeWitt
Journal:  Cell Immunol       Date:  1974-08       Impact factor: 4.868

5.  Prevention of blood transfusion-induced immunization against transplantation antigens by treatment of the blood with antibody.

Authors:  J W Fabre; J R Batchelor
Journal:  Transplantation       Date:  1975-12       Impact factor: 4.939

6.  A recombinant in the major histocompatibility complex of the rat.

Authors:  G W Butcher; J C Howard
Journal:  Nature       Date:  1977-03-24       Impact factor: 49.962

7.  Rat M immunoglobulin: isolation and some biological characteristics.

Authors:  P J Vriesman; J D Feldman
Journal:  Immunochemistry       Date:  1972-05

8.  Removal of leukocytes from whole blood and erythrocyte suspensions by filtration through cotton wool. I. Filtration technique.

Authors:  P Diepenhorst; R Sprokholt; H K Prins
Journal:  Vox Sang       Date:  1972       Impact factor: 2.144

9.  Adjuvant activity of erythrocyte isoantigens.

Authors:  L W Schierman; R A McBride
Journal:  Science       Date:  1967-05-05       Impact factor: 47.728

10.  Indium-111-labeled leukocytes for the localization of abscesses: preparation, analysis, tissue distribution, and comparison with gallium-67 citrate in dogs.

Authors:  M L Thakur; R E Coleman; M J Welch
Journal:  J Lab Clin Med       Date:  1977-01
View more
  1 in total

1.  Aberrancy in immunogenicity and cell-surface expression of H-2 antigens on erythrocytes.

Authors:  I Nakashima; T Yoshida; T Yokochi; K Ohashi; F Nagase; K Isobe; Y Hasegawa; K Ando; R Inagi
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.